The Pharmacy and Poisons Board (PPB) has begun reviewing an application to register Mounjaro, a booming once-weekly injectable diabetes drug, for use in Kenya.
The application was submitted by Aspen Pharmacare, a South African pharmaceutical company that has an agreement with Eli Lilly, the US manufacturer of Mounjaro, to distribute and promote the drug across sub-Saharan Africa.
